The pathogenesis of well differentiated liposarcoma (WDLPS) is poorly understood and pathologic characterization is often challenging. Descriptive terms (such as sclerosing, myxoid, inflammatory, spindle cell) are frequently encountered in the pathology reports and are of unknown clinical significance.
5-20% and worse patient prognosis. [4] [5] [6] However, the pathogenesis of WDLPS and DDLPS is poorly understood. Molecular analysis has
shown that WDLPS and DDLPS share the same cytogenetic features and are both characterized by amplification of chromosome 12q13-15, resulting in amplification of the MDM2 gene in virtually all cases and CDK4 in up to 90% of cases. [7] [8] [9] Although typically associated with a more favorable prognosis compared to DDLPS, the WDLPS subtype itself displays a wide range of clinical behavior and likely represents a spectrum of disease.
Pathologic interpretation may be difficult when fibrous or myxoid areas with increased cellularity or a slightly increased mitotic rate is present. Evans 
| MATERIALS AND METHODS

| Patient selection and clinicopathologic variables
After obtaining institutional review board approval, all adult patients (age Patient and tumor-related variables recorded included age at diagnosis, gender, race, tumor size, and tumor multifocality. Continuous variables (age, tumor size) were dichotomized using the median value. Final pathologic diagnosis as well as any applied pathologic descriptive qualifiers in the surgical pathology reports were abstracted and tabulated. "Typical" WDLPS were adipocytic tumors that were diagnosed as either atypical lipomatous tumor or WDLPS with no other features noted on pathologic review. Pathologic descriptive qualifiers in this study were grouped into 1) those concerning for but not meeting criteria for dedifferentiated liposarcoma; 2) cytologic atypia; 3) background changes (including "myxoid features," "myxoid background," "myxoid areas", "inflammation," and "sclerotic pattern"); Of the cohort, the pathologic diagnosis of WDLPS in 36 patients (58%) was associated with pathologic descriptive qualifiers ( Table 2 ).
The most common pathologic qualifiers applied in the description of the RP WDLPS tumors in this cohort included "focal areas of increased cellularity," "necrosis," "myxoid background," "hyalinization, fibrosis, sclerotic pattern," and "focal area of dedifferentiation/incipient | 
| Patient outcomes
Median follow-up was 72.8 months (range 9.5-248. We next performed univariable and multivariable analyses to identify factors associated with patient outcomes among patients who underwent complete (R0/R1) surgical resection of their primary WDLPS (Table 3) . On univariable analysis, the presence of pathologic descriptive qualifiers (HR 3.5, 95% CI 1.8-7.0, P = < 0.001) and presence of multifocal disease (HR 2.3, 95% CI 1.1-4.9, P = 0.028) were associated with worse LRFS. On multivariable analysis, we found that younger age (<55 years, HR 0.48, 95% CI 0.25-0.89, P = 0.021) and the presence of pathologic descriptive qualifiers with the diagnosis of WDLPS (HR 4.0, 95% CI 2.0-8.1, P < 0.001) were independent predictors of worse LRFS.
Although the presence of pathologic qualifiers with the diagnosis of WDLPS was independently associated with worse LRFS, in our models it was not independently predictive of DRFS or OS. inflammatory, and spindle cell), 7, 13, 14 this is the first study to evaluate the potential clinical implication of histologic differences within WDLPS on patient outcome. A previous study from The University of Texas MD Anderson Cancer Center described some of the variable pathologic characteristics seen in lipomatous tumors; however, this study included patients with lipomatous tumors occurring in the extremity and trunk, as well as tumors in the retroperitoneum. 10 As we have subsequently learned, the behavior of these tumors is very much location-specific and, therefore, limiting the scope of the patient population to the retroperitoneum will potentially provide a more accurate analysis and results. Patients in this study with primary WDLPS with pathologic descriptive qualifiers have better LRFS, DRFS, and OS outcomes than those historically reported for patients with DDLPS 6, 10 ; however, they fare worse than patients with typical WDLPS.
| DISCUSSION
Although up to 20% of patients with DDLPS may develop distant metastasis during their disease course, it is exceedingly uncommon for patients with WDLPS to develop distant metastases. One might suspect that the five patients in this study who developed distant metastases may, in fact, have had DDLPS rather than WDLPS at primary diagnosis (Supplementary Table S1 ). Of these five patients, only one patient was noted to have a focus of dedifferentiation not meeting criteria for diagnosis of DDLPS at primary WDLPS diagnosis.
This patient developed DDLPS at distant recurrence and had short OS of 13.3 months after initial diagnosis, raising concern that perhaps they indeed may have had primary DDLPS rather than WDLPS. Of the remaining four patients, one patient had "typical" WDLPS at primary WDLPS presentation and developed DDLPS at distant recurrence while the other three patients had WDLPS with pathologic qualifiers Over the study period in our institution, multiple sarcoma specialized pathologists have reviewed surgical resection specimens at our institution and there are likely inter-observer differences in the diagnosis of WDLPS and reporting of pathologic qualifiers. Indeed, we found notable variation in degree of detail and histologic findings described within pathology reports of surgical resection specimen (Table 2 ). Given the potential prognostic impact that various pathologic Bold numbers under P value column signify that P value is < 0.05.
| studies including the current study are also limited to potential selection bias as well as potential heterogeneity and changes in WDLPS multidisciplinary management and pathologic diagnosis and reporting over the study period.
In summary, this study is the first to examine and compare outcomes among patients who underwent surgical resection for primary WDLPS tumors of the retroperitoneum associated with pathologic descriptive qualifiers with those who underwent resection for primary typical WDLPS tumors. We found that primary retroperitoneal WDLPS with pathologic descriptive qualifiers were associated with worse LRFS and DRFS and appear to behave more aggressively than typical WDLPS. These findings suggest that there is a spectrum of clinical behavior and tumor aggressiveness within the currently defined WDLPS histologic subtype and that achieving a more detailed and reproducible pathologic description will allow for a better understanding of the disease spectrum and diversity of clinical behavior within WDLPS which will enable clinicians to provide more personalized treatment and improve patient outcome. We are currently evaluating new and reproducible pathologic markers that can potentially be used to more objectively identify tumors which are more likely to behave in a clinically aggressive fashion.
